429 results on '"Zheng, Xiangqian"'
Search Results
2. Author Correction: Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis
3. Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis
4. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma
5. Therapeutic targeting of TNIK in papillary thyroid carcinoma: a novel approach for tumor growth suppression
6. METTL3 inhibition induced by M2 macrophage-derived extracellular vesicles drives anti-PD-1 therapy resistance via M6A-CD70-mediated immune suppression in thyroid cancer
7. Efficacy and safety of selpercatinib in treating RET-altered MTC: A single-arm meta-analysis
8. Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery
9. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature
10. Effect of Aurora Kinase A Expression on Biochemical Cure in Patients after Medullary Thyroid Cancer Resection
11. ABCB11 accumulated in immature tertiary lymphoid structures participates in xenobiotic metabolic process and predicts resistance to PD-1/PD-L1 inhibitors in head and neck squamous cell carcinoma
12. Targeting Aurora-A inhibits tumor progression and sensitizes thyroid carcinoma to Sorafenib by decreasing PFKFB3-mediated glycolysis
13. Surgical selection and prognostic analysis in patients with unilateral sporadic medullary thyroid carcinoma
14. Consistent analysis of differentially expressed genes across 7 cell types in papillary thyroid carcinoma
15. Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAFV600E‐associated thyroid carcinoma
16. Cancer incidence and spectrum among Uygurs in Hotan District in China
17. Cathepsin F genetic mutation is associated with familial papillary thyroid cancer
18. Highly dispersed Ni/Al2O3 catalysts for dry reforming of methane prepared by alkaline-induced adsorption process
19. Deep learning to diagnose Hashimoto’s thyroiditis from sonographic images
20. Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects
21. Author Correction: Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
22. Targeting myeloid derived suppressor cells reverts immune suppression and sensitizes BRAF-mutant papillary thyroid cancer to MAPK inhibitors
23. CACA guidelines for holistic integrative management of thyroid cancer
24. Aurora kinase a promotes the progression of papillary thyroid carcinoma by activating the mTORC2-AKT signalling pathway
25. Activation of peroxymonosulfate by the CoFe/ZSM-5 for efficient sulfamethoxazole degradation
26. Regulation of the reaction pathway to design the high sulfur/coke-tolerant Ce-based catalysts for decomposing sulfur-containing VOCs
27. SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2‐Mediated Chromatin Remodeling.
28. An Inducible CRISPR‐dCas9‐Based Transcriptional Repression System for Cancer Therapy.
29. Establishment and validation of a nomogram model for predicting the survival probability of differentiated thyroid carcinoma patients: a comparison with the eighth edition AJCC cancer staging system
30. Efficacy and safety of pralsetinib in Chinese advanced RET-mutant medullary thyroid cancer patients
31. Safety and effectiveness of carbon nanoparticles suspension-guided lymph node dissection during thyroidectomy in patients with thyroid papillary cancer: a prospective, multicenter, randomized, blank-controlled trial
32. Targeting miR‐31 represses tumourigenesis and dedifferentiation of BRAFV600E‐associated thyroid carcinoma.
33. Analysis of Surgical Outcomes in Endoscopic‐Assisted Lateral Neck Dissection.
34. Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib
35. Predictive and prognostic value of aurora kinase A combined with tumor-infiltrating lymphocytes in medullary thyroid carcinoma
36. Analysis of Surgical Outcomes in Endoscopic‐Assisted Lateral Neck Dissection
37. Supplementary Table S4 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
38. Supplementary Methods S1 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
39. Data from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
40. Supplementary Figure S1 from Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
41. Ultrasound features of medullary thyroid cancer as predictors of biological behavior
42. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study
43. Assessment of the prognostic value and N1b changes of the eighth TNM/AJCC staging system for differentiated thyroid carcinoma
44. LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma
45. The first report of bilateral parapharyngeal lymph node metastasis from papillary thyroid carcinoma: A case report
46. Influence of Carbonization Conditions on Structural and Surface Properties of K-Doped Mo2C Catalysts for the Synthesis of Methyl Mercaptan from CO/H2/H2S
47. Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations
48. Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial
49. FATS regulates polyamine biosynthesis by promoting ODC degradation in an ERβ-dependent manner in non-small-cell lung cancer
50. Dysregulation of miR-551b-5p and SETD2 Predicts Poor Prognosis and Promotes Migration and Invasion of Thyroid Cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.